English
Home > Products > 2-Chloro-4-pyridinecarboxylic acid

China 2-Chloro-4-pyridinecarboxylic acid Factory

We rely upon strategic thinking, constant modernisation in all segments, technological advances and of course upon our employees that directly participate inside our success for 2-Chloro-4-pyridinecarboxylic acid,CAS NO 6313-54-8,6313-54-8, Trust us, you might discover a far better solution on car parts industry.
2-Chloro-4-pyridinecarboxylic acid, Our company promises: reasonable prices, short production time and satisfactory after-sales service, we also welcome you to visit our factory at any time you want. Wish we've got a pleasant and long terms business together!!!

Related Products

Hot Products

  • Lifitegrast

    Lifitegrast

    Product Name:Lifitegrast
    Molecular Formula:C29H24Cl2N2O7S
    Molecular Weight;615.48
    CAS Registry Number;1025967-78-5
  • 1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde

    1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde

    Product Name:1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde
    Molecular Formula:C11H19NO3
    Molecular Weight:213.27
    CAS Registry Number:137076-22-3
  • 6-Methoxyguanine

    6-Methoxyguanine

    Product Name:6-Methoxyguanine
    Molecular Formula:C6H7N5O
    Molecular Weight:165.15
    CAS Registry Number:20535-83-5
  • 2-Propenoic acid, 3-iodo, methyl ester, (Z)-

    2-Propenoic acid, 3-iodo, methyl ester, (Z)-

    Product Name:2-Propenoic acid, 3-iodo, methyl ester, (Z)-
    Molecular Formula:C4H5IO2
    Molecular Weight:211.99
    CAS Registry Number:6214-23-9
  • 2,3,4-Trifluorobenzoic acid

    2,3,4-Trifluorobenzoic acid

    Product Name:2,3,4-Trifluorobenzoic acid
    Molecular Formula:C7H3F3O2
    Molecular Weight:176.09
    CAS Registry Number:61079-72-9
  • N-Trityl Olmesartan Ethyl Ester

    N-Trityl Olmesartan Ethyl Ester

    Product Name:N-Trityl Olmesartan Ethyl Ester
    Molecular Formula:C45H44N6O3
    Molecular Weight:716.87
    CAS Registry Number:172875-59-1
  • Related Blog
  • Reviews

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept